Men 10376
Based on 1 publication(s) in Google Scholar
Men 10376 is a selective tachykinin NK-2 receptor antagonist, with a Ki of 4.4 μM for rat small intestine NK-2 receptor.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 135306-85-3
- Fòrmula: C57H68N12O10
- Peso molecular:1081.22
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Men 10376
More
Actividad biológica
Ki: 4.4 μM (NK-2 receptor, rat small intestine)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | EC50 |
78.1 nM
Compound: MEN-10376
|
Displacement of [3H]SR48968 from human recombinant NK2 receptor expressed in CHO cells
Displacement of [3H]SR48968 from human recombinant NK2 receptor expressed in CHO cells
|
[PMID: 16562853] |
Men 10376 is a selective tachykinin NK-2 receptor, with a Ki of 4.4 μM, and shows low selectivity for NK-1 and NK-3 receptors (Ki, >10 μM)[1]. Men 10376 shows pA2s of 5.66 and 8.08 for NK-1 (guinea-pig ileum) and NK-2 receptors (endothelium-deprived rabbit pulmonary artery). Men 10376 shows no effect on NK-3 receptor (Ki, >10 μM)[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 135306-85-3
-
Peso molecular 1081.22
-
Fòrmula C57H68N12O10
-
Synonyms
Neurokinin-2 receptor antagonist
-
Sequence
Asp-Tyr-{d-Trp}-Val-{d-Trp}-{d-Trp}-Lys-NH2
-
Sequence Shortening
DY-{d-Trp}-V-{d-Trp}{d-Trp}-K-NH2
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Pureza y Documentación
Referencias
[1]. Quartara L, et al. N-terminal truncated analogs of men 10376 as tachykinin NK-2 receptor antagonists. Life Sci. 1992;51(25):1929-36. [Content Brief]
[2]. Maggi CA, et al. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther. 1991 Jun;257(3):1172-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)